Overall, S15A behaviour and seizure phenotypes mirror to some extent human clinical manifestations of CDD, arguing that slowed inactivation and enhanced cholinergic modulation of unphosphorylated Cav2.3 may contribute to these symptoms. The gene discussed is CACNA1E; the disease is craniodiaphyseal dysplasia.